子宮頸癌形成的原因現今已知與乳狀突病毒 (HPV) 有密切關係 | |
。當子宮頸上皮細胞受到感染,並由此乳狀突病毒提供子宮頸額外 | |
的核酸 (DNA),子宮頸細胞便容易發生突變而產生癌症。人類乳突 | |
狀病毒總計至今已有九十種以上, 人類乳突狀病毒可分為“低危 | |
險亞型”與“高危險亞型”兩大類。 現今已經知道至少有35種高 | |
危險亞型的人類乳突狀病毒是與子宮頸癌的發生形成有關,其中最 | |
重要與常見的型態種類有HPV-16, 18, 31, 33, 35, 52, 58等數種,而 | |
這些高危險亞型的人類乳突狀病毒感染與子宮頸癌前期病變或子宮 | |
頸癌的相關性,約在百分之80 至90之間, 至今許多醫學論文也都 | |
已證實人類乳突狀病毒是導致產生子宮頸癌最主要的原因之一,總 | |
結這些相關論文,可得下列數項結論: | |
一、 | 乳狀突病毒的染色體基因可分為 ” L ” 與 ” E ” 兩大類, |
當子宮頸細胞感染乳狀突病毒後,乳狀突病毒的染色體基因 | |
便進入人體的子宮頸細胞中,當乳狀突病毒的染色體E2斷裂 | |
後,它的病毒基因便會和子宮頸細胞的染色體基因結合,這 | |
樣病毒的 E6基因便會和子宮頸細胞的癌症抑制基因 ( tumor | |
suppressor gene P53) 結合, 而阻礙了P53基因抑制細胞過度生 | |
長的作用,同時 E7 會和子宮頸細胞的 E2F 酵素結合, 而導致 | |
另一個癌症抑制基因 (Rb-E2F) 的控制細胞增值功能喪失,就 | |
因為E6及E7的作用,便會導致子宮頸細胞的增值失控與癌病 | |
變形成。在子宮頸癌形成原因中,僅有少數是與乳狀突病毒 | |
沒有關聯的,其原因可能的是直接在子宮頸細胞的癌症抑制 | |
基因(P53, Rb) 上的基因突變,而導致癌症抑制基因的功能喪 | |
失,進而產生癌病變。 | |
二、 | 乳狀突病毒的感染途徑主要為經由性行為接觸, 或經由血液 |
及體液感染, 不過亦可以經由懷孕與生產途徑來傳染, 現 | |
今已知有多位性伴侶,年齡過早有性行為,或與色情職業的 | |
高危險對象發生性行為等的不安全性行為,均會增加乳狀突 | |
病毒的感染機會。我們先前的研究已顯示在台灣,乳狀突病 | |
毒在有性行為女性的感染率約為百分之十五至二十五左右, | |
不過在未婚沒有性行為的年輕女性亦有約百分之四至七的感 | |
染率,亦有文獻報告指出在美國大學年輕未婚女學生的感染 | |
率約有三分之一,其中四分之一將會形成病毒的持續性感染 | |
( persistent infection),而高危險亞型HPV持續性感染的婦女 | |
中、約三分之一將來會形成子宮頸癌前期病變 (CIN), 如罹 | |
患 CIN 未被治療或未被發現, 則 4% (CIN I) 至30% (CIN III) | |
的患者將來會演變成子宮頸癌,所以高危險亞型的HPV持續 | |
感染婦女,是很需要被照顧的子宮頸癌高危險群。所以對乳 | |
狀突病毒的感染認知與衛教將會是一個是很重要的課題。 | |
1. |
感染人類乳突狀病毒的婦女,四分之一將會形成乳突狀病毒 |
的持續性感染者。 | |
2. |
許多醫學文獻已證實感染高危險亞型人類乳突狀病毒的婦女 |
約三分之一會形成子宮頸癌前期病變。 | |
3. |
子宮頸癌前期病變患者如未治療或未被發現, 則 4% (CIN I) |
至30% (CIN III) 的患者將來會演變成子宮頸癌。 | |
基於上述原因, 所以大家已有共識:如果婦女感染高危險亞 | |
型的人類乳突狀病毒﹙HPV DNA type 16、 18、 31、 33、 35、39 | |
、45、 51、 52、 56、 58、59、 及 68﹚, 那麼她就是屬於子宮 | |
頸癌的高危險族群了。因為已婚的婦女約百分之二十是有人類乳突 | |
狀病毒的感染, 而這些也正是好發子宮頸癌的高危險群婦女, 然 | |
而現在台灣只有百分之二十至三十的已婚婦女是有做過子宮頸抹片 | |
檢查的,所以遺漏了很多的潛伏患者 (平均計算, 遺漏了百分之七 | |
十的高危險群), 所以以類似“肝癌的肝炎病毒檢驗模式”, 利用 | |
乳突狀病毒基因檢測來做子宮頸癌高危險群的篩檢,經由乳突狀病 | |
毒的基因檢驗技術,事先得知哪些婦女是屬於較容易發生子宮頸癌 | |
的高危險群婦女,那麼將可以提高這些婦女對疾病的認知,讓他們 | |
對疾病不再有漠視的情形存在,進而提高這些婦女定期做子宮頸抹 | |
片的意願。雖然人類乳突狀病毒的感染,至今仍無有效藥物可供治 | |
療,但是對於這些較易發生子宮頸癌的婦女, 以密切追蹤及觀察 | |
來面對、並衛教定期做子宮頸抹片, 將可以避免遺漏了這些屬於 | |
較容易發生子宮頸癌的高危險群婦女不去做抹片。 | |
現今許多國家已經開始採用人類乳突狀病毒的基因檢驗來做 | |
全國婦女的子宮頸癌高危險群篩檢, 其中包括英國、歐聯 (丹麥、 | |
瑞典)、紐西蘭等, 美國也已開始著手評估其臨床價值, 其中英國 | |
並已有初步文獻報告刊登於國際癌症雜誌。 總結來說, 這些論文 | |
認為婦女子宮頸癌高危險群篩檢可以降低全國(英國) 婦女30% 到 | |
60% 的子宮頸癌罹患機會; 英國女性 (15歲以上) 如果一生只做一 | |
次人類乳突狀病毒的高危險群檢驗, 則可以降低30% 罹患子宮頸 | |
癌的機會,如果每五年做一次人類乳突狀病毒的基因檢驗, 則可 | |
以降低 60%得到子宮頸癌的機會。 | |
我們研究小組利用人類乳突狀病毒的檢測, 對子宮頸癌的先 | |
期研究顯示, 人類乳突狀病毒檢查對於子宮頸癌或是子宮頸癌前 | |
期的相關性有百分之84, 而子宮頸抹片檢查對於子宮頸癌或是子 | |
宮頸癌前期的偵測準確率為百分之71, 如果合併此兩種檢查, 則 | |
對於子宮頸癌或是子宮頸癌前期的偵測準確率可以提昇至百分之 | |
91,這結果顯示人類乳突狀病毒的檢查,確實可以提高子宮頸癌的 | |
早期診斷;近年醫學論文也認為,人類乳突狀病毒的檢驗比同時間 | |
多次的反覆抹片更俱有早期診斷的臨床意義,所以在子宮頸抹片檢 | |
查的推廣政策下,實施乳突狀病毒檢驗是可以輔助子宮頸抹片檢 | |
查,並提高異常子宮頸的檢出率、及降低子宮頸抹片的偽陰性。 | |
人類乳突狀病毒的檢測,除了運用在提高抹片篩檢率、 降低 | |
偽陰性外,也可以運用在下列幾個方向: | |
1. |
對抹片為 ASCUS或LSIL 的診斷, 可以提高正確率與降低偽 |
陽性,如檢測為病毒陽性, 則需做陰道鏡切片或進一步的圓 | |
錐切片。 | |
2. |
對做過圓錐切片的病歷, 可以運用人類乳突狀病毒的檢測作 |
為復發的預測指標、或作為邊緣是否完整的生化指標。 | |
3. | 針對做過放射線治療的病患, 因抹片判讀常受到放射線影響 |
而不容易判讀,導致許多的偽陽性與偽陰性,因此可以運用 | |
人類乳突狀病毒的檢測作為抹片的生化指標。 | |
4. | 針對高齡婦女的癌症篩檢,人類乳突狀病毒的檢測準確性與 |
子宮頸抹片有同等準確效益。 |
Molecular
Mechenism
Ⅰ.Human
papillomavirus:
A
DNA tumor virus with a doule-strand close circular DNA genome of 7900 bases.
More than 70 types identified with most of them associated with the skun
infection andabout 27 types infect the ano-genital mucosa.It encodes 8 genes
which express 14 protin products.
Function
of HPV transcripts:
E1:
act on origin of replication to induce episomal DNA replication.
E2:
together with E1 forms origin binding complex. Also a transcription regulator,
Particularly a repressor of the E6 promoter.
E4:
Act with intermediate filaments of host cell, associate wih viral particle
release.
E5a:
Anoncoprotein related to the signal transduction of host cell. Act on the ER,
Golgi, related to the endocellular trafficking.
E6:
Anoncogene, inactivation of p53 tumor suppresser gene.
E7:
An oncogene, inactivation of Rb tumor suppresser gene.
E7
gene alone of either low or high risk HPV transactivate host DNA replication
In the differention of squamouse epithelium.
Differentiation of host cell is required to turn on the E6/E7 promoter
and hence Induction of host DNA replication.
L1:
External capsid protein of the hexahedral capsid.
L2:
Internal capsid protein of the hexahedral capsid.
A
productive life cycle of HPV depends on the differention of squamous
epithelium. So far it is very difficult to culture HPV. The identification of
HPV relies on DNA detection. The weak systemic antigenicity makes serological
test both insensitive and nonspecific.
Ⅱ.Human
Papillomavirus and Cervical Cancer:
1.
Epidemiology:
There
are 5000,000 new cases of cervical or anal cancer each year around the world,
which are related with the HPV infection. Cervical cancer has been the leading
prevalent cancer in Taiwan since 1985.
HPV
16, 18 are related to the development of squamous, adeno-and small cell
carcinoma of cervij, avd metastasis of the cervical cancer.
PHYLOGENETIC
TREE OF HPV BASED ON AMINO ACID SEQUENCES
About
50-80% of CIN patient have HPV infection, 90% or more human cervical cancers
contain HPV DNA. Those remaining HPV(-) cervical cell lines have p53 or RB
gene mutation. The most prevalent HPV type in cervical cancer is type 16,
folloewd by type 18, 31, 33. In Taiwan and fareast countries, type58, next to
type 16 is the second most prevalent type.
The
prevalence of HPV infection in genital tract is about 25% of female less than
55 years old. The lifelong risk of HPV(+) women to develop cancer is about
3.7%. It usually takes 20 to 50 years.
Patholphysiology:
(A)
HPV infection
The
primary infection site of HPV is at the squamous-columnar(S-C) junction of
Cervical epithelium, where the cells are actively proliferating. The columnar
epithelial cells at the S-C junction toeard the endocervix with age. Most
cervical cancer occurs at the region between the new and old S-C junctions,
which is therefor named “transforming
zone”.
The original S-C junction of a teenage girl is more exposed at the exocervix
and cells within are more vulnerable to HPV infection if she has early sexual
exposure. Other estrogen-excess status that leads to cervical extropian and
vulnerability include pregnancy and use of oral pills. The way of HPV entry
into the epithelium is unknown, probably is through injured (erotic) or
inflamatory epithelium and get into the basal (stem) cells.
HPV
Transmission
•
Cutaneous HPVs are transmitted casually.
•
Genital HPVs are transmitted sexually.
Important
variables for acquisition:
-
Age at first intercourse
-
Number of sex partners
-
Coincident STDs
-
Immunc status
(B)
Integration of HPV DNA into host genome
HPV
DNA is usually extrachromosomal in CIN lesions. In malignment lesion Viral DNA
is usually found to be integrated. The integration disrupt HPV circular genome
at the E2 gene which is a repressor for E6/E7 promoter. This results in an
over-expression of E6 and E7 oncogenes. No specificity has been observed for
intrachromosomal localizations of HPV integration. One report disclose HPV 16
integrated near the c-src, c-raf and c-myc oncogenes. A small percentage of
malignant tumors harbors only nonintegrated copies of viral DNA. The
integration is clonal in nature indicating the HPV infection precedes the
tumor growth.
The
infection of HPV is tissue (i. e. keratinocyte) specific. The abundant AP-1 in
Keratinocyte but not fibroblast may be responsible, since there is a crucial
AP-1 binding site at the E6 promoter.
B)
E6 and E7 oncogenes
The
vast majority of HPV-positive cancer cells express high level of E6 and E7.
E6,
E7 genes from high risk HPV together are capable of immortalizing primary
human keratinocytes, subsequent transfection with v-ras, or after long-time
culture, may lead to malignant clones.
Protein
products of deregulated E6 and E7 genes bind to tumor repressor gene
products,p53 and pRb, and leads to loss of function of these tumor suppressor
proteins.p53 and pRb, are also bound to other viral oncoproteins such as E1b
(p53) and E1a (pRb) of adenovirus, and large T antigen (both) of SV40 virus.
Expression
of the high risk HPVs may lead to aneuploidy (change of chromosome number) and
contribute to the other cellular events necessary for a full cancer
development.
E7
protein only is sufficient to turn on the DNA replication machinery. E7 binds
Rb
protein, ieading to its sequestration to an inactive form. The pRb normally
activate the transfection factor E2F, which is a major machinery to activate
the expression of a lot of replication related enzymes and entry into the cell
cycle. The major role of E2F is the transcriptional activation of cellular
genes that encod proteins important for creating the S phase environment and
allowing DNA replication to occur. E6 targeted at the cell cycle check point
controlled by p53 which is bound and degraded by E6.
3.
Natural history of HPV infection
It
generally takes 5 to 10 years for LSIL to progress to HSIL and another 10 to
20 years to invasive Ca. About 1/3 of HPV infection persisted, 1/10 progress
to CIN and less than 1/100 ti Ca.
2.
Histological Change of HPV infection:
A)
Condyloma acuminata: Papillomatosis, acanthosis with hyperkeratosis,
parakeratosis, presence of nuclear atypia and periunclear hals (koilocytosis).
B)
Low grade squamous intraepithelial lesion (LSIL): Aberrant
differentiation (mild dysplasia), perinuclear atypia (Koilocytes), absence of
abnormal mitotic figure. Comparable to CIN Ⅰ.
C)
High grade squamous intraepithelial lesion (HSIL): Plus the presence of
abnormal mitotic figure. Comparable to CIN II,III and CIS.
*Flat
cervical condyloma and low grade CIN have the same histology picture.
*Nuclear
atycality: enlarged hyperchromatis smudged nuclei, empty or fragmenting
nuclei.
*Abnormal
mitotic figure: multinucleation, abnormal metaphase, bizarre forms,empty
or
fragmenting.
III. Perspective of HPV Infection Disease
Other
Etiologic Factors of Cervical Carcinogenesis:
Infection
of HPVis essential but both insefficient and insufficient for cervical
carcinogenesis. In thedevelopment of cancer, it usually takes sij or more “hit”
on critical growth control genes (oncogenes or tumor suppresser genes).
Infection of HPV leads to inactivation of p53 and Rb, but other etiologic
factors are required for the other 4 or more “hits”.
Smoking, estrogen and other chronic infections are proven risk factors. All
are genotoxic which may lead to genomic instability (or microsatellite
instability) and rapid accumulation of genetic hits.